International consensus statement on allergy and rhinology: Allergic rhinitis – 2023. Issue 4 (6th March 2023)
- Record Type:
- Journal Article
- Title:
- International consensus statement on allergy and rhinology: Allergic rhinitis – 2023. Issue 4 (6th March 2023)
- Main Title:
- International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
- Authors:
- Wise, Sarah K.
Damask, Cecelia
Roland, Lauren T.
Ebert, Charles
Levy, Joshua M.
Lin, Sandra
Luong, Amber
Rodriguez, Kenneth
Sedaghat, Ahmad R.
Toskala, Elina
Villwock, Jennifer
Abdullah, Baharudin
Akdis, Cezmi
Alt, Jeremiah A.
Ansotegui, Ignacio J.
Azar, Antoine
Baroody, Fuad
Benninger, Michael S.
Bernstein, Jonathan
Brook, Christopher
Campbell, Raewyn
Casale, Thomas
Chaaban, Mohamad
Chew, Fook Tim
Chambliss, Jeffrey
Cianferoni, Antonella
Custovic, Adnan
Davis, Elizabeth Mahoney
DelGaudio, John M.
Ellis, Anne K.
Flanagan, Carrie
Fokkens, Wytske J.
Franzese, Christine
Greenhawt, Matthew
Gill, Amarbir
Halderman, Ashleigh
Hohlfeld, Jens M.
Incorvaia, Cristoforo
Joe, Stephanie A.
Joshi, Shyam
Kuruvilla, Merin Elizabeth
Kim, Jean
Klein, Adam M.
Krouse, Helene J.
Kuan, Edward C.
Lang, David
Larenas‐Linnemann, Desiree
Laury, Adrienne M.
Lechner, Matt
Lee, Stella E.
Lee, Victoria S.
Loftus, Patricia
Marcus, Sonya
Marzouk, Haidy
Mattos, Jose
McCoul, Edward
Melen, Erik
Mims, James W.
Mullol, Joaquim
Nayak, Jayakar V.
Oppenheimer, John
Orlandi, Richard R.
Phillips, Katie
Platt, Michael
Ramanathan, Murugappan
Raymond, Mallory
Rhee, Chae‐Seo
Reitsma, Sietze
Ryan, Matthew
Sastre, Joaquin
Schlosser, Rodney J.
Schuman, Theodore A.
Shaker, Marcus S.
Sheikh, Aziz
Smith, Kristine A.
Soyka, Michael B.
Takashima, Masayoshi
Tang, Monica
Tantilipikorn, Pongsakorn
Taw, Malcolm B.
Tversky, Jody
Tyler, Matthew A.
Veling, Maria C.
Wallace, Dana
Wang, De Yun
White, Andrew
Zhang, Luo
… (more) - Other Names:
- Ahmed Omar G. investigator.
Arianpour Khashayar investigator.
Barrow Emily investigator.
Cavaliere Carlo investigator.
Cantu Juan Carlos Ceballos investigator.
Chaskes Mark B. investigator.
Chua Andy Jian Kai investigator.
Daggumati Srihari investigator.
Daines Luke investigator.
Daraei Paul investigator.
Edwards Thomas investigator.
Gigliotti Deanna investigator.
Gore Mitchell investigator.
Goshtasbi Khodayar investigator.
Han Doo Hee investigator.
Hossenbaccus Lubnaa investigator.
Jolicoeur Megan investigator.
Kanjanawasee Dichapong investigator.
Kilic Suat investigator.
Linton Sophia investigator.
Liu David investigator.
Low Christoper investigator.
Mahomva Chengetai investigator.
Malenke Jordan A. investigator.
Miglani Amar investigator.
Nagy Peter investigator.
Park Jin‐A investigator.
Paz‐Lansberg Marianella investigator.
Pfeffer Paul investigator.
Ryan Marisa investigator.
Saraswathula Anirudh investigator.
Sheehan Cameron investigator.
Struss Nadja investigator.
Tie Kevin investigator.
Torabi Sina investigator.
Tsai Esmond F. investigator.
Velasquez Nathalia investigator.
Vuncannon Jackson investigator.
Watley Duncan investigator.
Xu Xinni investigator.
… (more) - Abstract:
- Abstract: Background: In the 5 years that have passed since the publication of the 2018 International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis 2018), the literature has expanded substantially. The ICAR‐Allergic Rhinitis 2023 update presents 144 individual topics on allergic rhinitis (AR), expanded by over 40 topics from the 2018 document. Originally presented topics from 2018 have also been reviewed and updated. The executive summary highlights key evidence‐based findings and recommendation from the full document. Methods: ICAR‐Allergic Rhinitis 2023 employed established evidence‐based review with recommendation (EBRR) methodology to individually evaluate each topic. Stepwise iterative peer review and consensus was performed for each topic. The final document was then collated and includes the results of this work. Results: ICAR‐Allergic Rhinitis 2023 includes 10 major content areas and 144 individual topics related to AR. For a substantial proportion of topics included, an aggregate grade of evidence is presented, which is determined by collating the levels of evidence for each available study identified in the literature. For topics in which a diagnostic or therapeutic intervention is considered, a recommendation summary is presented, which considers the aggregate grade of evidence, benefit, harm, and cost. Conclusion: The ICAR‐Allergic Rhinitis 2023 update provides a comprehensive evaluation of AR and the currently availableAbstract: Background: In the 5 years that have passed since the publication of the 2018 International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis 2018), the literature has expanded substantially. The ICAR‐Allergic Rhinitis 2023 update presents 144 individual topics on allergic rhinitis (AR), expanded by over 40 topics from the 2018 document. Originally presented topics from 2018 have also been reviewed and updated. The executive summary highlights key evidence‐based findings and recommendation from the full document. Methods: ICAR‐Allergic Rhinitis 2023 employed established evidence‐based review with recommendation (EBRR) methodology to individually evaluate each topic. Stepwise iterative peer review and consensus was performed for each topic. The final document was then collated and includes the results of this work. Results: ICAR‐Allergic Rhinitis 2023 includes 10 major content areas and 144 individual topics related to AR. For a substantial proportion of topics included, an aggregate grade of evidence is presented, which is determined by collating the levels of evidence for each available study identified in the literature. For topics in which a diagnostic or therapeutic intervention is considered, a recommendation summary is presented, which considers the aggregate grade of evidence, benefit, harm, and cost. Conclusion: The ICAR‐Allergic Rhinitis 2023 update provides a comprehensive evaluation of AR and the currently available evidence. It is this evidence that contributes to our current knowledge base and recommendations for patient evaluation and treatment. … (more)
- Is Part Of:
- International forum of allergy & rhinology. Volume 13:Issue 4(2023)
- Journal:
- International forum of allergy & rhinology
- Issue:
- Volume 13:Issue 4(2023)
- Issue Display:
- Volume 13, Issue 4 (2023)
- Year:
- 2023
- Volume:
- 13
- Issue:
- 4
- Issue Sort Value:
- 2023-0013-0004-0000
- Page Start:
- 293
- Page End:
- 859
- Publication Date:
- 2023-03-06
- Subjects:
- allergen extract -- allergen immunotherapy -- allergy -- allergic rhinitis -- antihistamine -- asthma -- atopic dermatitis -- avoidance -- biologic -- cockroach -- conjunctivitis -- consensus -- corticosteroid -- cough -- cromolyn -- decongestant -- eosinophilic esophagitis -- environment -- epicutaneous -- immunotherapy -- epidemiology -- evidence‐based medicine -- food allergy -- house dust mite -- IgE -- immunoglobulin E -- immunotherapy -- inhalant allergy -- leukotriene -- microbiome -- occupational rhinitis -- omalizumab -- pediatric -- perennial -- pet dander -- pollen -- probiotic -- rhinitis -- rhinosinusitis -- saline -- seasonal -- sensitization -- sinusitis -- socioeconomic -- specific IgE -- subcutaneous immunotherapy -- sublingual immunotherapy -- systematic review -- rhinitis -- total IgE -- transcutaneous immunotherapy -- validated survey
617.51005 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2042-6984 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/alr.23090 ↗
- Languages:
- English
- ISSNs:
- 2042-6976
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4540.330250
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 26385.xml